Roberto Vendramin

4.1k citations
12 papers · 453 · h-index 6

Impact in

    • Cancer-related molecular mechanisms research
    • Cancer Genomics and Diagnostics
    • MicroRNA in disease regulation
    • RNA modifications and cancer
    • RNA Research and Splicing
    • Mitochondrial Function and Pathology
    • RNA and protein synthesis mechanisms
    • Circular RNAs in diseases

Papers in

    • RNA modifications and cancer 5
    • RNA Research and Splicing 5
    • Protein Degradation and Inhibitors 2
    • Melanoma and MAPK Pathways 2
    • RNA and protein synthesis mechanisms 2
    • Histone Deacetylase Inhibitors Research 1
    • Cancer-related molecular mechanisms research 5
    • Cancer Genomics and Diagnostics 2

Roberto Vendramin

12 papers receiving 450 citations

Peers

Roberto Vendramin
Comparison fields: 5 of 72
  • Cancer Research 229
  • Molecular Biology 308
  • Oncology 66
  • Modeling and Simulation 12
  • Aging 3
Replace Vivien Low with:
Vivien Low United States
Daneen Schaeffer United States
Karl-Henning Kalland Norway
Tiziana La Bella France
Matthew Holmes United States
Byungho Lim South Korea
Sebastian M. Dieter Germany
Vanja Radulović Germany
Lisa van Voorthuijsen Netherlands
J-Y. Hung Taiwan
Roberto Vendramin relative to Vivien Low United States Vivien Low's profile →
Citations per field
00.5×
Vivien Low · 1×
Citations per year

Countries citing papers authored by Roberto Vendramin

Since Specialization
Citations

This map shows the geographic impact of Roberto Vendramin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Vendramin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Vendramin more than expected).

Fields of papers citing papers by Roberto Vendramin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Vendramin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Vendramin. The network helps show where Roberto Vendramin may publish in the future.

Co-authors

The 25 scholars most cited alongside Roberto Vendramin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberto Vendramin Line = papers co-authored together Roberto Vendramin links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 2021149
2 2017103
3 201889
4 202041
5 202129
6 202028
7 20155
8 20235
9 20241
10 20251
11 20221
12 20201

About Roberto Vendramin

Roberto Vendramin is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Genetics, having authored 12 papers that have together received 453 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA Research and Splicing (5 papers), Cancer Genomics and Diagnostics (2 papers), Protein Degradation and Inhibitors (2 papers), Melanoma and MAPK Pathways (2 papers), RNA and protein synthesis mechanisms (2 papers) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Cancer Research (229 citations), Molecular Biology (308 citations), Oncology (66 citations), Modeling and Simulation (12 citations) and Aging (3 citations). Roberto Vendramin has collaborated with scholars based in Belgium, United Kingdom and Italy. Frequent co-authors include Charles Swanton, Kevin Litchfield, Eleonora Leucci, Jean‐Christophe Marine, Gian Gaetano Tartaglia, Denis L. J. Lafontaine, Nobuhiro Takahashi, Pieter Mestdagh, Riccardo Delli Ponti and Hideaki Ishikawa. Their work appears in journals such as Nucleic Acids Research, The EMBO Journal, Cancer Research, The Journal of Experimental Medicine and Nature Structural & Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact